-+ 0.00%
-+ 0.00%
-+ 0.00%

Mirum Pharmaceuticals names Rob Myers chief medical officer effective Sept. 21, 2026

PUBT·09/08/2026 12:31:01
Listen to the news
Mirum Pharmaceuticals names Rob Myers chief medical officer effective Sept. 21, 2026
  • Mirum named Rob Myers as chief medical officer, effective Sept. 21, 2026, to lead global medical and clinical development.
  • Myers joins from OrsoBio, where he served as chief medical officer and head of development.
  • He previously held senior roles at Gilead Sciences, overseeing clinical development across liver fibrosis, cholestatic liver diseases, gastrointestinal inflammation.
  • Outgoing chief medical officer Joanne Quan will depart the company.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609080830BIZWIRE_USPR_____20260908_BW078641) on September 08, 2026, and is solely responsible for the information contained therein.